Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Statistics

Total Valuation

STO:CLS.B has a market cap or net worth of SEK 72.64 million. The enterprise value is 42.19 million.

Market Cap	72.64M
Enterprise Value	42.19M

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:CLS.B has 25.67 million shares outstanding. The number of shares has increased by 204.91% in one year.

Current Share Class	25.66M
Shares Outstanding	25.67M
Shares Change (YoY)	+204.91%
Shares Change (QoQ)	+36.87%
Owned by Insiders (%)	1.64%
Owned by Institutions (%)	2.98%
Float	25.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.61
PB Ratio	1.02
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.84
EV / Sales	2.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.88

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.00.

Current Ratio	4.43
Quick Ratio	3.53
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-95.14

Financial Efficiency

Return on equity (ROE) is -85.15% and return on invested capital (ROIC) is -47.83%.

Return on Equity (ROE)	-85.15%
Return on Assets (ROA)	-40.94%
Return on Invested Capital (ROIC)	-47.83%
Return on Capital Employed (ROCE)	-64.43%
Revenue Per Employee	1.18M
Profits Per Employee	-2.97M
Employee Count	17
Asset Turnover	0.29
Inventory Turnover	0.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.31% in the last 52 weeks. The beta is -0.00, so STO:CLS.B's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	-55.31%
50-Day Moving Average	2.88
200-Day Moving Average	4.01
Relative Strength Index (RSI)	46.34
Average Volume (20 Days)	128,711

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLS.B had revenue of SEK 20.14 million and -50.45 million in losses. Loss per share was -3.43.

Revenue	20.14M
Gross Profit	13.98M
Operating Income	-45.67M
Pretax Income	-50.52M
Net Income	-50.45M
EBITDA	-43.00M
EBIT	-45.67M
Loss Per Share	-3.43

Balance Sheet

The company has 27.87 million in cash and 224,000 in debt, giving a net cash position of 27.65 million or 1.08 per share.

Cash & Cash Equivalents	27.87M
Total Debt	224,000
Net Cash	27.65M
Net Cash Per Share	1.08
Equity (Book Value)	70.87M
Book Value Per Share	2.90
Working Capital	32.18M

Cash Flow

In the last 12 months, operating cash flow was -45.15 million and capital expenditures -2.87 million, giving a free cash flow of -48.02 million.

Operating Cash Flow	-45.15M
Capital Expenditures	-2.87M
Free Cash Flow	-48.02M
FCF Per Share	-1.87

Margins

Gross margin is 69.40%, with operating and profit margins of -226.75% and -250.51%.

Gross Margin	69.40%
Operating Margin	-226.75%
Pretax Margin	-250.85%
Profit Margin	-250.51%
EBITDA Margin	-213.49%
EBIT Margin	-226.75%
FCF Margin	n/a

Dividends & Yields

STO:CLS.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-204.91%
Shareholder Yield	n/a
Earnings Yield	-69.46%
FCF Yield	-66.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2024. It was a reverse split with a ratio of 0.005.

Last Split Date	Apr 25, 2024
Split Type	Reverse
Split Ratio	0.005

Scores

STO:CLS.B has an Altman Z-Score of 4.25.

Altman Z-Score	4.25
Piotroski F-Score	n/a